Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in Ann Hematol Retrieve available abstracts of 161 articles: HTML format

Single Articles

April 2023
1. IGLESIAS-VAZQUEZ L, Gimeno M, Coronel P, Caspersen IH, et al
   Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study.
   Ann Hematol. 2023;102:741-748.
   PubMed     Abstract available
   
   
   
2. ZHANG Y, Pan J, Kang H, Peng S, et al
   Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments.
   Ann Hematol. 2023;102:801-809.
   PubMed     Abstract available
   
   
   March 2023
3. DING K, Liu Z, Ren Y, Liu H, et al
   Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients.
   Ann Hematol. 2023 Mar 13. doi: 10.1007/s00277-022-04997.
   PubMed    
   
   
   
4. AHMADI M, Beiranvand S, Poormansouri S, Matbouei M, et al
   Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients.
   Ann Hematol. 2023;102:519-528.
   PubMed     Abstract available
   
   
   February 2023
5. VERSTOVSEK S
   How I manage anemia related to myelofibrosis and its treatment regimens.
   Ann Hematol. 2023 Feb 14. doi: 10.1007/s00277-023-05126.
   PubMed     Abstract available
   
   
   
6. WANG H, Liu H, Li L, Chen Y, et al
   Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria.
   Ann Hematol. 2023;102:299-309.
   PubMed     Abstract available
   
   
   
7. FU X, Zhao X, Weng A, Zhang Q, et al
   Comparative efficacy and safety of restrictive versus liberal transfusion thresholds in anemic preterm infants: a meta-analysis of 12 randomized controlled trials.
   Ann Hematol. 2023;102:283-297.
   PubMed     Abstract available
   
   
   
8. MELONI A, Pistoia L, Quota A, Messina G, et al
   Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients.
   Ann Hematol. 2023;102:261-270.
   PubMed     Abstract available
   
   
   January 2023
9. JIN Y, Li R, Lin S, Jia J, et al
   Correction to: A real‑world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
   Ann Hematol. 2023 Jan 26. doi: 10.1007/s00277-023-05107.
   PubMed    
   
   
   
10. ZHANG L, Mao J, Lian Y, Liang Q, et al
    Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine.
    Ann Hematol. 2023 Jan 21:1-11. doi: 10.1007/s00277-023-05097.
    PubMed     Abstract available
    
    
    
11. TANTAWY A, El-Sherif N, Makkeyah S, Eldeen NS, et al
    Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study.
    Ann Hematol. 2023 Jan 16. doi: 10.1007/s00277-023-05099.
    PubMed     Abstract available
    
    
    
12. SHEN Y, Liu Q, Li H, Liu W, et al
    Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.
    Ann Hematol. 2023 Jan 9. doi: 10.1007/s00277-023-05086.
    PubMed     Abstract available
    
    
    
13. CURTIS S, Henny B, Joanna S, Betancourt J, et al
    Excess deaths among adults with sickle cell disease in 2020 compared to prior years.
    Ann Hematol. 2023;102:41-44.
    PubMed     Abstract available
    
    
    December 2022
14. ZHANG JY, Li Y, Ma YS, Sun XJ, et al
    Clinical characteristics and prognostic factors in intracranial hemorrhage patients with hematological diseases.
    Ann Hematol. 2022;101:2617-2625.
    PubMed     Abstract available
    
    
    November 2022
15. FUTAGI Y, Suga Y, Shimada T, Sai Y, et al
    Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients.
    Ann Hematol. 2022 Nov 26. doi: 10.1007/s00277-022-05063.
    PubMed    
    
    
    
16. MUSALLAM KM, Cappellini MD, Daar S, El-Beshlawy A, et al
    Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent beta-thalassemia.
    Ann Hematol. 2022 Nov 14. pii: 10.1007/s00277-022-05046.
    PubMed    
    
    
    
17. DELEHAYE F, Rouger J, Brossier D, Suttorp M, et al
    Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course.
    Ann Hematol. 2022 Nov 12. pii: 10.1007/s00277-022-05024.
    PubMed     Abstract available
    
    
    
18. BANZIGER S, Weisshaar K, Arokoski R, Gerull S, et al
    Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).
    Ann Hematol. 2022 Nov 3. pii: 10.1007/s00277-022-05012.
    PubMed     Abstract available
    
    
    
19. PIATTI G, Giuditta M, Consonni D, Cassinerio E, et al
    Cardiopulmonary testing in adult patients with beta-thalassemia major in comparison to healthy subjects.
    Ann Hematol. 2022;101:2445-2452.
    PubMed     Abstract available
    
    
    
20. ZHANG R, Chen M, Yang C, Han B, et al
    Efficacy and steroid-sparing effect of tacrolimus in patients with autoimmune cytopenia.
    Ann Hematol. 2022;101:2421-2431.
    PubMed     Abstract available
    
    
    
21. HAN B, Ji J, Zhang B, Bai H, et al
    The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2022;101:2537-2539.
    PubMed    
    
    
    October 2022
22. FAN J, Lu R, Yu K, Zhang Y, et al
    Very severe aplastic anemia with papillary thyroid carcinoma: treatment with allo-HSCT-a case report and literature review.
    Ann Hematol. 2022 Oct 21. pii: 10.1007/s00277-022-05009.
    PubMed    
    
    
    
23. YANG W, Zhao X, He G, Chang H, et al
    Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study.
    Ann Hematol. 2022 Oct 11. pii: 10.1007/s00277-022-04968.
    PubMed     Abstract available
    
    
    
24. ROTH A, Barcellini W, Tvedt THA, Miyakawa Y, et al
    Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study.
    Ann Hematol. 2022;101:2169-2177.
    PubMed     Abstract available
    
    
    
25. THEDSAWAD A, Wanachiwanawin W, Taka O, Hantaweepant C, et al
    Cut-off values for diagnosis of G6PD deficiency by flow cytometry in Thai population.
    Ann Hematol. 2022;101:2149-2157.
    PubMed     Abstract available
    
    
    
26. LIU XD, Yang K, Xiao J, Huang H, et al
    Whole exome sequencing identifies a novel SPTB frameshift mutation causing hereditary spherocytosis in the Chinese population.
    Ann Hematol. 2022;101:2355-2357.
    PubMed    
    
    
    September 2022
27. HU J, Zhang L, Zhao X, Liu X, et al
    First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.
    Ann Hematol. 2022 Sep 24. pii: 10.1007/s00277-022-04952.
    PubMed     Abstract available
    
    
    
28. EL-AMIN N, Iness A, Cyrus JW, Sisler I, et al
    Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis.
    Ann Hematol. 2022;101:1931-1940.
    PubMed     Abstract available
    
    
    
29. CELLA D, Sarda SP, Hsieh R, Fishman J, et al
    Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study.
    Ann Hematol. 2022;101:1905-1914.
    PubMed     Abstract available
    
    
    
30. WONG RSM, Pullon HWH, Amine I, Bogdanovic A, et al
    Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria.
    Ann Hematol. 2022;101:1971-1986.
    PubMed     Abstract available
    
    
    
31. PADRAO EMH, Bustos B, Mahesh A, Fonseca GHH, et al
    Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort.
    Ann Hematol. 2022;101:1951-1957.
    PubMed     Abstract available
    
    
    
32. MELONI A, Barbuto L, Pistoia L, Positano V, et al
    Frequency, pattern, and associations of renal iron accumulation in sickle/beta-thalassemia patients.
    Ann Hematol. 2022;101:1941-1950.
    PubMed     Abstract available
    
    
    August 2022
33. JIN Y, Li R, Lin S, Jia J, et al
    A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
    Ann Hematol. 2022 Aug 27. pii: 10.1007/s00277-022-04966.
    PubMed     Abstract available
    
    
    
34. BEYAR-KATZ O, Perry C, On YB, Amit O, et al
    Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells-single-center experience.
    Ann Hematol. 2022;101:1769-1776.
    PubMed     Abstract available
    
    
    
35. ZHOU F, Zhang F, Zhang L, Wu Q, et al
    A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia.
    Ann Hematol. 2022;101:1785-1794.
    PubMed     Abstract available
    
    
    
36. PIRIYAKHUNTORN P, Tantiworawit A, Kasitanon N, Louthrenoo W, et al
    Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia.
    Ann Hematol. 2022;101:1667-1675.
    PubMed     Abstract available
    
    
    
37. JAFRI F, Seong G, Jang T, Cimpeanu E, et al
    L-glutamine for sickle cell disease: more than reducing redox.
    Ann Hematol. 2022;101:1645-1654.
    PubMed     Abstract available
    
    
    
38. LOBITZ S, Frommel C, Brose A, Blankenstein O, et al
    Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.
    Ann Hematol. 2022;101:1859-1860.
    PubMed    
    
    
    July 2022
39. AL-KURAISHY HM, Al-Gareeb AI, Kaushik A, Kujawska M, et al
    Hemolytic anemia in COVID-19.
    Ann Hematol. 2022 Jul 8. pii: 10.1007/s00277-022-04907.
    PubMed     Abstract available
    
    
    
40. HAN B, Kim HJ, Yhim HY, Oh D, et al
    Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study.
    Ann Hematol. 2022;101:1435-1445.
    PubMed     Abstract available
    
    
    
41. JUNG EH, Park JH, Hwan Kim K, Kim JS, et al
    Characteristics of Sweet syndrome in patients with or without malignancy.
    Ann Hematol. 2022;101:1499-1508.
    PubMed     Abstract available
    
    
    
42. ROPERO P, Gonzalez Fernandez FA, Nieto JM, Recasens V, et al
    Does size matter? Two new deletions in the HBB gene cause beta(0)-thalassemia.
    Ann Hematol. 2022;101:1465-1471.
    PubMed     Abstract available
    
    
    
43. WU X, Cheng L, Liu X, Sun Y, et al
    Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia.
    Ann Hematol. 2022;101:1493-1498.
    PubMed     Abstract available
    
    
    
44. PATSOURAKOS D, Aggeli C, Gatzoulis KA, Delicou S, et al
    Left atrial deformation indices in beta-thalassemia major patients.
    Ann Hematol. 2022;101:1473-1483.
    PubMed     Abstract available
    
    
    
45. ADAM AS, Cotton F, Cantinieaux B, Benyaich S, et al
    Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters?
    Ann Hematol. 2022;101:1485-1491.
    PubMed     Abstract available
    
    
    
46. COSTANTINI S, Meloni A, Spasiano A, Cinque P, et al
    The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia.
    Ann Hematol. 2022;101:1621-1623.
    PubMed    
    
    
    June 2022
47. MA X, Zuo Y, Xu Z, Zhang Y, et al
    Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
    Ann Hematol. 2022 Jun 23. pii: 10.1007/s00277-022-04885.
    PubMed     Abstract available
    
    
    
48. HWANG YY, Chan TSY, Chan FHY, Lau CWP, et al
    Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
    Ann Hematol. 2022;101:1163-1172.
    PubMed     Abstract available
    
    
    
49. ZHOU X, Jiang P, Gao L, Yang J, et al
    Immune reconstitution and survival of patients with parvovirus B19 related pure red cell aplasia after haplo-PBSCT.
    Ann Hematol. 2022;101:1333-1342.
    PubMed     Abstract available
    
    
    
50. ESCRIBANO SERRAT S, Del Campo Balguerias G, Martinez Nieto J, Medina Salazar F, et al
    Pincered red cells in hereditary spherocytosis.
    Ann Hematol. 2022;101:1393-1394.
    PubMed    
    
    
    May 2022
51. PIRES DA SILVA BGP, Fonseca NP, Catto LFB, Pereira GC, et al
    The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center.
    Ann Hematol. 2022;101:999-1007.
    PubMed     Abstract available
    
    
    
52. POPLAWSKA M, Dutta D, Jayaram M, Chong NS, et al
    Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease.
    Ann Hematol. 2022;101:1009-1013.
    PubMed     Abstract available
    
    
    April 2022
53. KAYNAR LA, Gokcen S, Can F, Yegin ZA, et al
    Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia.
    Ann Hematol. 2022 Apr 23. pii: 10.1007/s00277-022-04835.
    PubMed     Abstract available
    
    
    
54. WERNER R, Lohr B, Lodemann P, Chemnitz JM, et al
    Autoimmune basal ganglia encephalitis with hemolytic anemia.
    Ann Hematol. 2022 Apr 21. pii: 10.1007/s00277-022-04848.
    PubMed    
    
    
    
55. PROCHASKA MT, Huisingh-Scheetz M, Meltzer D
    Sex differences in fatigue and symptoms of anemia in relation to hemoglobin level in hospitalized patients.
    Ann Hematol. 2022 Apr 11. pii: 10.1007/s00277-022-04830.
    PubMed    
    
    
    
56. LI S, Guo P, Mi L, Chai X, et al
    A novel SPTB mutation causes hereditary spherocytosis via loss-of-function of beta-spectrin.
    Ann Hematol. 2022;101:731-738.
    PubMed     Abstract available
    
    
    March 2022
57. BAHATI YL, Delanghe J, Balaluka GB, Philippe J, et al
    Exploration of the relationship between anemia and iron and zinc deficiencies in children under 5 years of age living in the malaria endemic area of South Kivu/Democratic Republic of Congo.
    Ann Hematol. 2022 Mar 23. pii: 10.1007/s00277-022-04816.
    PubMed     Abstract available
    
    
    
58. TOLU SS, Crouch A, Choi J, Gao Q, et al
    Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.
    Ann Hematol. 2022;101:541-548.
    PubMed     Abstract available
    
    
    
59. LUFTINGER R, Zubarovskaya N, Galimard JE, Cseh A, et al
    Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.
    Ann Hematol. 2022;101:655-665.
    PubMed     Abstract available
    
    
    
60. BAYRAKTAROGLU S, Karadas N, Onen S, Karapinar DY, et al
    Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.
    Ann Hematol. 2022;101:521-529.
    PubMed     Abstract available
    
    
    
61. SOULIERES D, Mercier-Ross J, Fradette C, Rozova A, et al
    The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease.
    Ann Hematol. 2022;101:533-539.
    PubMed     Abstract available
    
    
    
62. LI S, Chen K, Huang C, Zhang N, et al
    First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation.
    Ann Hematol. 2022;101:617-619.
    PubMed     Abstract available
    
    
    
63. ROSETTI M, De la Salle B, Farneti G, Clementoni A, et al
    The added value of digital morphological analysis in the evaluation of peripheral blood films: the report of an UKNEQAS external quality assessment sample.
    Ann Hematol. 2022;101:729-730.
    PubMed    
    
    
    
64. FARFAN-QUIROGA G, Hermosilla-Fernandez MDM, Feliu-Sanchez J, Najera-Irazu MJ, et al
    A new case of Bicetre hemoglobin in an adult male: clinical observations over a period of four years.
    Ann Hematol. 2022;101:701-702.
    PubMed    
    
    
    February 2022
65. VIROT E, Thuret I, Jardel S, Herbrecht R, et al
    Pregnancy outcome in women with transfused beta-thalassemia in France.
    Ann Hematol. 2022;101:289-296.
    PubMed     Abstract available
    
    
    
66. MARTINS SR, Toledo SLO, da Silva AJ, Mendes FS, et al
    Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?
    Ann Hematol. 2022;101:273-280.
    PubMed     Abstract available
    
    
    
67. DINGLI D, Matos JE, Lehrhaupt K, Krishnan S, et al
    The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey.
    Ann Hematol. 2022;101:251-263.
    PubMed     Abstract available
    
    
    
68. HOSOKAWA K, Nakao S
    Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti.
    Ann Hematol. 2022;101:461-464.
    PubMed    
    
    
    
69. BRANDO B, Gatti A
    Re: Hosokawa K et al. Assay sensitivity of flow cytometric PNH analysis.
    Ann Hematol. 2022;101:459-460.
    PubMed    
    
    
    
70. DAS S, Karmakar K, Mukherjee R, Panda S, et al
    Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-beta thalassemia.
    Ann Hematol. 2022;101:449-451.
    PubMed    
    
    
    January 2022
71. SUN YX, Feng Q, Wang SW, Li X, et al
    HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.
    Ann Hematol. 2022 Jan 18. pii: 10.1007/s00277-022-04757.
    PubMed     Abstract available
    
    
    
72. GHANEM P, Marrone K, Shanbhag S, Brahmer JR, et al
    Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.
    Ann Hematol. 2022;101:1-10.
    PubMed     Abstract available
    
    
    
73. YILDIRIM N, Unal S, Yalcinkaya A, Karahan F, et al
    Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Ann Hematol. 2022;101:35-41.
    PubMed     Abstract available
    
    
    
74. SOKOL J, Guman T, Chudej J, Hlebaskova M, et al
    Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.
    Ann Hematol. 2022;101:81-89.
    PubMed     Abstract available
    
    
    
75. ABULHAMAIL A, AlShebli A, Merdad L, Wali S, et al
    Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study.
    Ann Hematol. 2022;101:43-57.
    PubMed     Abstract available
    
    
    
76. TARTAGLIONE I, Manara R, di Concilio R, Quarta A, et al
    Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.
    Ann Hematol. 2022;101:241-242.
    PubMed    
    
    
    
77. MUSALLAM KM, Cappellini MD, Daar S, Taher AT, et al
    Morbidity-free survival and hemoglobin level in non-transfusion-dependent beta-thalassemia: a 10-year cohort study.
    Ann Hematol. 2022;101:203-204.
    PubMed    
    
    
    
78. ACQUAVIVA G, Nonne G, Murtas A, Longu F, et al
    Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia.
    Ann Hematol. 2022;101:227-228.
    PubMed    
    
    
    
79. DEBUREAUX PE, Ruggiu M, Mathis S, Mirouse A, et al
    Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.
    Ann Hematol. 2022;101:219-221.
    PubMed    
    
    
    December 2021
80. EL-KHAZRAGY N, Matbouly S, Hanna DH, Mahran NA, et al
    Circulating miRNAs and tissue iron overload in transfusion-dependent beta-thalassemia major: novel predictors and follow-up guide.
    Ann Hematol. 2021;100:2909-2917.
    PubMed     Abstract available
    
    
    
81. KARIMI M, Zarei T, Bahmanimehr A, Aramesh A, et al
    Long-term safety and efficacy of hydroxyurea in patients with non-transfusion-dependent beta-thalassemia: a comprehensive single-center experience.
    Ann Hematol. 2021;100:2901-2907.
    PubMed     Abstract available
    
    
    November 2021
82. VIVES-CORRONS JL, Krishnevskaya E, Hernandez-Rodriguez I, Payan-Pernia S, et al
    Red cell ektacytometry in two patients with chronic hemolytic anemia and three new alpha-spectrin variants.
    Ann Hematol. 2021 Nov 29. pii: 10.1007/s00277-021-04723.
    PubMed     Abstract available
    
    
    
83. JIANG Z, Jiang X, Chen M
    Severe aplastic anemia in a patient with erythropoietic protoporphyria successfully treated by avatrombopag.
    Ann Hematol. 2021 Nov 26. pii: 10.1007/s00277-021-04726.
    PubMed    
    
    
    
84. MATSUYAMA Y, Hosoi H, Horitani R, Kawamoto S, et al
    Management of warm autoimmune hemolytic anemia related to band 3-positive colon carcinoma.
    Ann Hematol. 2021 Nov 5. pii: 10.1007/s00277-021-04714.
    PubMed    
    
    
    
85. DUCA L, Nava I, Tavazzi D, Marcon A, et al
    Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years.
    Ann Hematol. 2021;100:2683-2688.
    PubMed     Abstract available
    
    
    
86. KULAGIN AD, Ptushkin VV, Lukina EA, Davydkin IL, et al
    Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.
    Ann Hematol. 2021;100:2689-2698.
    PubMed     Abstract available
    
    
    
87. TEAWTRAKUL N, Chansai S, Yamsri S, Ungarreevittaya P, et al
    JAK2V617F mutation in patients with beta-thalassemia disease: prevalence and clinical characteristics.
    Ann Hematol. 2021;100:2863-2865.
    PubMed    
    
    
    October 2021
88. EL FAKIH R, Alfraih F, Alhayli S, Ahmed SO, et al
    Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts.
    Ann Hematol. 2021 Oct 31. pii: 10.1007/s00277-021-04708.
    PubMed     Abstract available
    
    
    
89. BIASSI TP, Guerra-Shinohara EM, Moretti PNS, de Freitas Dutra V, et al
    miRNA profile and disease severity in patients with sickle cell anemia.
    Ann Hematol. 2021 Oct 22. pii: 10.1007/s00277-021-04665.
    PubMed     Abstract available
    
    
    
90. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia.
    Ann Hematol. 2021 Oct 14. pii: 10.1007/s00277-021-04696.
    PubMed     Abstract available
    
    
    
91. SHOKRGOZAR N, Karimi M, Golmoghaddam H, Rezaei N, et al
    Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in beta-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.
    Ann Hematol. 2021;100:2463-2469.
    PubMed     Abstract available
    
    
    
92. ABDULHAI F, Jaffa MA, Elias J, Zakka P, et al
    Digital thermography and vascular involvement in beta-thalassemia intermedia.
    Ann Hematol. 2021;100:2471-2477.
    PubMed     Abstract available
    
    
    September 2021
93. HIRAMOTO N, Yamazaki H, Nakamura Y, Uchida N, et al
    Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.
    Ann Hematol. 2021 Sep 21. pii: 10.1007/s00277-021-04664.
    PubMed     Abstract available
    
    
    
94. THONG EWS, Tan SS, Sethi SK, Chee YL, et al
    Falsely elevated serum vitamin B12 levels in a case of pernicious anemia.
    Ann Hematol. 2021 Sep 10. pii: 10.1007/s00277-021-04612.
    PubMed    
    
    
    
95. WOUTERS HJCM, Conrads-Frank A, Koinig KA, Smith A, et al
    The anemia-independent impact of myelodysplastic syndromes on health-related quality of life.
    Ann Hematol. 2021 Sep 2. pii: 10.1007/s00277-021-04654.
    PubMed     Abstract available
    
    
    
96. JANG T, Mo G, Stewart C, Khoury L, et al
    Obesity and diabetes mellitus in patients with sickle cell disease.
    Ann Hematol. 2021;100:2203-2205.
    PubMed     Abstract available
    
    
    
97. BOGA C, Asma S, Leblebisatan G, Sen N, et al
    Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
    Ann Hematol. 2021;100:2195-2202.
    PubMed     Abstract available
    
    
    August 2021
98. CHENOU F, Hounkpe BW, Domingos IF, Tonasse WV, et al
    Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Ann Hematol. 2021 Aug 28. pii: 10.1007/s00277-021-04636.
    PubMed     Abstract available
    
    
    
99. YAMADA S, Kajikawa S, Nakagawa N, Kondo Y, et al
    Coombs' test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs' test negative after azacitidine administration.
    Ann Hematol. 2021 Aug 27. pii: 10.1007/s00277-021-04652.
    PubMed    
    
    
    
100. ATIPIMONPAT A, Siwaponanan P, Khuhapinant A, Svasti S, et al
     Extracellular vesicles from thalassemia patients carry iron-containing ferritin and hemichrome that promote cardiac cell proliferation.
     Ann Hematol. 2021;100:1929-1946.
     PubMed     Abstract available
     
     
     
101. TRANEKAER S, Hansen DL, Biemond BJ, Sorensen AL, et al
     Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
     Ann Hematol. 2021;100:1947-1951.
     PubMed     Abstract available
     
     
     
102. SINGHA K, Fucharoen G, Fucharoen S
     delta-Hemoglobinopathies in Thailand: screening, molecular basis, genotype-phenotype interaction, and implication for prevention and control of thalassemia.
     Ann Hematol. 2021;100:1953-1963.
     PubMed     Abstract available
     
     
     
103. HOSOKAWA K, Ishiyama K, Ikemoto T, Sugimori C, et al
     The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
     Ann Hematol. 2021;100:1975-1982.
     PubMed     Abstract available
     
     
     
104. OKAMOTO H, Uoshima N, Kamitsuji Y, Kawata E, et al
     Paroxysmal nocturnal hemoglobinuria complicated with essential thrombocythemia harboring concomitant PIGA, CALR, and ASXL1 mutations.
     Ann Hematol. 2021;100:2113-2115.
     PubMed    
     
     
     
105. ROBIER C, Hoefler G, Aubell K, Hubmann E, et al
     Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1.
     Ann Hematol. 2021;100:2111-2112.
     PubMed    
     
     
     
106. JAMWAL M, Mallik N, Aravindan AV, Jain A, et al
     Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis.
     Ann Hematol. 2021;100:2107-2109.
     PubMed    
     
     
     July 2021
107. NORASETTHADA L, Wongkhantee S, Chaipokam J, Charoenprasert K, et al
     Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study.
     Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04566.
     PubMed     Abstract available
     
     
     
108. YANG W, Zhao X, Peng G, Zhang L, et al
     Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
     Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04553.
     PubMed     Abstract available
     
     
     
109. CAO J, Pei R, Zhang P, Liu X, et al
     Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
     Ann Hematol. 2021 Jul 6. pii: 10.1007/s00277-021-04497.
     PubMed     Abstract available
     
     
     
110. GOREN SAHIN D, Akay OM, Keklik M, Okan V, et al
     Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
     Ann Hematol. 2021;100:1667-1675.
     PubMed     Abstract available
     
     
     
111. ELZAEEM DI, Sharkawi EAE, Zaki EM, Ghobrial AG, et al
     Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients.
     Ann Hematol. 2021;100:1701-1709.
     PubMed     Abstract available
     
     
     
112. NJUE L, Medri C, Keller P, Diepold M, et al
     The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review.
     Ann Hematol. 2021;100:1677-1683.
     PubMed     Abstract available
     
     
     
113. RICCHI P, Costantini S, Spasiano A, Cinque P, et al
     Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.
     Ann Hematol. 2021;100:1907-1910.
     PubMed    
     
     
     
114. MUSALLAM KM, Cappellini MD, Taher AT
     Variations in hemoglobin level and morbidity burden in non-transfusion-dependent beta-thalassemia.
     Ann Hematol. 2021;100:1903-1905.
     PubMed    
     
     
     
115. TRAN QUANG V, Tarfi S, Loustau V, Moutereau S, et al
     A belated diagnosis of G6PD deficiency in an 81-year-old woman.
     Ann Hematol. 2021;100:1901-1902.
     PubMed    
     
     
     June 2021
116. BATISTA JVGF, Pereira-Martins DA, Falcao DA, Domingos IF, et al
     Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
     Ann Hematol. 2021 Jun 14. pii: 10.1007/s00277-021-04532.
     PubMed     Abstract available
     
     
     
117. KRECAK I, Cengic M, Skoric I, Nakic M, et al
     Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
     Ann Hematol. 2021 Jun 10. pii: 10.1007/s00277-021-04570.
     PubMed    
     
     
     
118. AL-TAWFIQ JA, Rabaan AA, AlEdreesi MH
     Frequency of bacteremia in patients with sickle cell disease: a longitudinal study.
     Ann Hematol. 2021;100:1411-1416.
     PubMed     Abstract available
     
     
     
119. ARPACI A, Gul BU, Ozcan O, Ilhan G, et al
     Presentation of two new mutations in the 3'untranslated region of the beta-globin gene and evaluating the molecular spectrum of thalassemia mutations in the Mediterranean region of Turkey.
     Ann Hematol. 2021;100:1429-1438.
     PubMed     Abstract available
     
     
     
120. BHURANI D, Kapoor J, Yadav N, Khushoo V, et al
     Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
     Ann Hematol. 2021;100:1417-1427.
     PubMed     Abstract available
     
     
     
121. MAROUF R, Adekile AD, El-Muzaini H, Abdulla R, et al
     Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.
     Ann Hematol. 2021;100:1401-1409.
     PubMed     Abstract available
     
     
     
122. TAMAI Y, Ito S, Hasegawa A
     Paroxysmal nocturnal haemoglobinuria associated with a novel phosphatidylinositol glycan class A (PIGA) mutation in a patient with Klinefelter syndrome.
     Ann Hematol. 2021;100:1625-1627.
     PubMed    
     
     
     May 2021
123. HERBRETEAU L, Le Calloch R, Arnaud B, Cassou N, et al
     Eculizumab, a real-life successful treatment for refractory cold agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders.
     Ann Hematol. 2021 May 18. pii: 10.1007/s00277-021-04557.
     PubMed    
     
     
     
124. QIN X, Zhu YP, Luo CJ, Zhou M, et al
     Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.
     Ann Hematol. 2021 May 14. pii: 10.1007/s00277-021-04540.
     PubMed     Abstract available
     
     
     
125. BALLAS SK
     Opioids are not a major cause of death of patients with sickle cell disease.
     Ann Hematol. 2021;100:1133-1138.
     PubMed     Abstract available
     
     
     April 2021
126. MENDOZA E, Duque X, Moran S, Martinez-Andrade G, et al
     Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
     Ann Hematol. 2021;100:879-890.
     PubMed     Abstract available
     
     
     
127. RAMSAY Z, Gabbadon CH, Asnani M
     Numb chin syndrome in sickle cell disease: a case series of Jamaican patients.
     Ann Hematol. 2021;100:913-919.
     PubMed     Abstract available
     
     
     
128. HATAIRAKTHAM S, Masaratana P, Hantaweepant C, Srisawat C, et al
     Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent beta-thalassemia/Hb E patients.
     Ann Hematol. 2021;100:891-901.
     PubMed     Abstract available
     
     
     March 2021
129. YOUSSEF JG, Zahiruddin F, Youssef G, Padmanabhan S, et al
     G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
     Ann Hematol. 2021;100:667-673.
     PubMed     Abstract available
     
     
     
130. SAEIDNIA M, Nowrouzi-Sohrabi P, Erfani M, Fazeli P, et al
     The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with beta-thalassemia intermedia: a randomized double-blind clinical trial.
     Ann Hematol. 2021;100:627-633.
     PubMed     Abstract available
     
     
     
131. VERMA HK, Ratre YK, Bhaskar LVKS, Colombatti R, et al
     Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy.
     Ann Hematol. 2021;100:607-614.
     PubMed     Abstract available
     
     
     
132. HAGHPANAH S, Cohan N, Bordbar M, Bazrafshan A, et al
     Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent beta-thalassemia.
     Ann Hematol. 2021;100:635-644.
     PubMed     Abstract available
     
     
     
133. SCHULLER H, Klein F, Lubbert M, Prager EP, et al
     Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report.
     Ann Hematol. 2021;100:841-842.
     PubMed    
     
     
     
134. MISTRY RH, Kohut A, Ford P
     Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
     Ann Hematol. 2021;100:661-666.
     PubMed     Abstract available
     
     
     February 2021
135. HSIEH TC, Sostin O
     Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids.
     Ann Hematol. 2021 Feb 18. pii: 10.1007/s00277-021-04457.
     PubMed    
     
     
     
136. HATZLHOFER BLD, Pereira-Martins DA, de Farias Domingos I, Arcanjo GDS, et al
     Alpha thalassemia, but not beta(S)-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.
     Ann Hematol. 2021 Feb 13. pii: 10.1007/s00277-021-04450.
     PubMed     Abstract available
     
     
     
137. LADEIRA VS, Barbosa AR, Oliveira MM, Ferreira LGR, et al
     ADAMTS-13-VWF axis in sickle cell disease patients.
     Ann Hematol. 2021;100:375-382.
     PubMed     Abstract available
     
     
     
138. KUMAR R, Yadav R, Mishra S, Singh MPSS, et al
     Kruppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities.
     Ann Hematol. 2021;100:365-373.
     PubMed     Abstract available
     
     
     
139. BATISTA JVGF, Arcanjo GS, Batista THC, Sobreira MJ, et al
     Influence of UGT1A1 promoter polymorphism, alpha-thalassemia and beta(s) haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.
     Ann Hematol. 2021 Feb 1. pii: 10.1007/s00277-021-04422.
     PubMed     Abstract available
     
     
     January 2021
140. MARTYNOVA A, Chiu V, Mert M, Hermel D, et al
     Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
     Ann Hematol. 2021 Jan 9. pii: 10.1007/s00277-021-04401.
     PubMed     Abstract available
     
     
     
141. STACY S, Sheth S, Coleman B, Cerenzia W, et al
     An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.
     Ann Hematol. 2021;100:27-35.
     PubMed     Abstract available
     
     
     December 2020
142. GIORDANO G, Napolitano M, Di Battista V, Lucchesi A, et al
     Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
     Ann Hematol. 2020 Dec 2. pii: 10.1007/s00277-020-04361.
     PubMed     Abstract available
     
     
     
143. WU Y, Yao Q, Zhong M, Wu J, et al
     Genetic research and clinical analysis of deletional Chinese (G)gamma(+)((A)gammadeltabeta)(0) -thalassemia and Southeast Asian HPFH in South China.
     Ann Hematol. 2020;99:2747-2753.
     PubMed     Abstract available
     
     
     
144. SINHA S, Jit BP, Patro ARK, Ray A, et al
     Influence of rs1042713 and rs1042714 polymorphisms of beta2-adrenergic receptor gene with erythrocyte cAMP in sickle cell disease patients from Odisha State, India.
     Ann Hematol. 2020;99:2737-2745.
     PubMed     Abstract available
     
     
     
145. PAZGAL I, Yahalom V, Shalev B, Raanani P, et al
     Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel.
     Ann Hematol. 2020;99:2731-2736.
     PubMed     Abstract available
     
     
     November 2020
146. MENDEZ M, Moreno-Carralero MI, Peri VL, Camacho-Galan R, et al
     Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene.
     Ann Hematol. 2020 Nov 7. pii: 10.1007/s00277-020-04319.
     PubMed     Abstract available
     
     
     
147. RUAN J, Zuo W, Chen M, Yang C, et al
     Correction to: Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
     Ann Hematol. 2020 Nov 2. pii: 10.1007/s00277-020-04301.
     PubMed     Abstract available
     
     
     
148. ABDULLAH N, Ismail N, Abd Jalal N, Mohd Radin F, et al
     Prevalence of anaemia and associated risk factors amongst The Malaysian Cohort participants.
     Ann Hematol. 2020;99:2521-2527.
     PubMed     Abstract available
     
     
     
149. DESAI RJ, Mahesri M, Globe D, Mutebi A, et al
     Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries.
     Ann Hematol. 2020;99:2497-2505.
     PubMed     Abstract available
     
     
     
150. BALLAS SK, Dampier C
     Risk factors associated with increased emergency department utilization in patients with sickle cell disease: a systematic literature review.
     Ann Hematol. 2020;99:2483-2495.
     PubMed     Abstract available
     
     
     
151. KIRITO K
     Expansion of paroxysmal nocturnal hemoglobinuria clones in MPLW515L mutation harboring primary myelofibrosis.
     Ann Hematol. 2020;99:2707-2709.
     PubMed    
     
     
     
152. TRIPATHI P, Agarwal S, Gupta A, Mandal K, et al
     Biallelic rare 17 bp deletion mutation (HBB:c.380_396 del TGCAGGCTGCCTATCAG) in a transfusion depended form of thalassemia.
     Ann Hematol. 2020;99:2719-2722.
     PubMed    
     
     
     October 2020
153. WAN K, Yin Y, Luo Z, Cheng J, et al
     Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
     Ann Hematol. 2020 Oct 16. pii: 10.1007/s00277-020-04300.
     PubMed     Abstract available
     
     
     
154. ONISHI Y, Mori T, Yamazaki H, Takenaka K, et al
     Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
     Ann Hematol. 2020 Oct 9. pii: 10.1007/s00277-020-04290.
     PubMed     Abstract available
     
     
     
155. LAN Y, Chang L, Yi M, Cai Y, et al
     Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.
     Ann Hematol. 2020 Oct 8. pii: 10.1007/s00277-020-04296.
     PubMed     Abstract available
     
     
     
156. ONISHI Y, Yokoyama H, Katsuoka Y, Ito T, et al
     Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma.
     Ann Hematol. 2020;99:2351-2356.
     PubMed     Abstract available
     
     
     
157. FUREDER W, Sperr WR, Heibl S, Zebisch A, et al
     Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
     Ann Hematol. 2020;99:2303-2313.
     PubMed     Abstract available
     
     
     
158. BUTTARI B, Profumo E, Caprari P, Massimi S, et al
     Phenotypical and functional abnormalities of circulating neutrophils in patients with beta-thalassemia.
     Ann Hematol. 2020;99:2265-2277.
     PubMed     Abstract available
     
     
     
159. EL-GHAMRAWY M, Yassa ME, Tousson AMS, El-Hady MA, et al
     Association between BCL11A, HSB1L-MYB, and XmnI gammaG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
     Ann Hematol. 2020;99:2279-2288.
     PubMed     Abstract available
     
     
     
160. CHUANG TY, Li JP, Weng TF, Wu KH, et al
     Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
     Ann Hematol. 2020;99:2289-2294.
     PubMed     Abstract available
     
     
     
161. FRIEDRICH C, Gay J, Alary AS, Arlet JB, et al
     Battle of the clones: paroxysmal nocturnal hemoglobinuria vs myelodysplastic syndrome.
     Ann Hematol. 2020;99:2459-2461.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: